Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Open-market sale Senior Vice President sold 25,625 shares at an average $64.57 ($1,654,591)
  2. 4 Open-market sale Director sold 4,500 shares at an average $64.72 ($291,244)
  3. 4 Open-market sale Director sold 4,050 shares at an average $64.75 ($262,233)
  4. 4 Open-market sale Director sold 4,500 shares at an average $64.71 ($291,177)
  5. 4 Open-market sale Director sold 4,500 shares at an average $64.71 ($291,192)
  6. 4 Grant or award Senior Vice President acquired 55,000 shares (grant or award)
  7. 4 Option exercise General Counsel acquired 28,000 shares (option exercise)
  8. 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 800,000 shares (grant or award)
  10. 4 Open-market buy Director bought 655 shares at $66.37 ($43,472)
  11. 4 Open-market sale Director sold 3,400 shares at $66.82 ($227,188)
  12. 4 Option exercise Chief Executive Officer acquired 11,806 shares (option exercise)
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 8-K Event Regulation FD disclosure
  15. 4 Open-market sale Chief Executive Officer sold 60,000 shares at an average $67.56 ($4,053,431)
  16. 8-K Event Other events
  17. 4 Open-market sale Chief Medical Officer sold 19,500 shares at an average $69.31 ($1,351,589)
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. 4 Open-market sale Chief Executive Officer sold 65,000 shares at an average $65.77 ($4,274,982)

Page 19 of 69 · 1,363 filings